Company patents
Cellino Biotech, Inc.
Cellino Biotech, Inc.'s patent strategy appears to be heavily concentrated in Bioreactors / Cell Culture Apparatus, which accounts for 92.9% of its portfolio, despite a significant decline of 60.0% in 2025 and 25.0% so far in 2026. Surprisingly, the company has shown a dramatic shift away from Material & Chemical Analysis and Laboratory Apparatus, both experiencing a 100.0% decline in patenting activity so far in 2026, indicating a potential refocusing of R&D efforts.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
28 US filings (since 2023) · 9 categories · 6 themes
Systems and methods for automated monitoring and dynamic adjustment of environmental parameters (e.g., pH, temperature, oxygen, nutrients) and fluid handling within bioreactors to optimize cell/tissue growth or product synthesis.
Devices and systems designed for the cultivation of cells or tissues, often incorporating three-dimensional structures or controlled interfaces to mimic in-vivo environments for biological research or production.
Methods and apparatus specifically tailored for the expansion, differentiation, or genetic modification of cells for therapeutic applications (e.g., CAR T cells, progenitor cells) or for the production of specific biological products (e.g., cultured fat, RNA).
Techniques and apparatus for cultivating cells in three-dimensional structures, including organoids, tissue models, and scaffolds, often involving microfluidics, specialized matrices, or mechanical stimulation to mimic in vivo conditions.
Delivery systems specifically engineered to administer advanced drug formulations (e.g., microparticles, biologics, extended-release systems) to achieve precise targeting, controlled release kinetics, or enhanced therapeutic efficacy within the body.
Development of lipid-based nanoparticles, liposomes, or other molecular platforms to encapsulate and deliver therapeutic agents, particularly nucleic acids, to target tissues or improve pharmacokinetics.
Patents
Showing 1-10 of 12
Cell Therapy & Bioproduction Processes